Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Clinical trial NCT06593392 · RECRUITING
Trial details
- NCT number
- NCT06593392
- Sponsor
- Vifor Fresenius Medical Care Renal Pharma
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-17
- Primary completion
- 2029-08-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.